|
ZFYVE1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.03583808197527E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.99618099827603E-13 |
| Normal-vs-Stage2 |
7.10619996180384E-09 |
| Normal-vs-Stage3 |
3.229300E-04 |
| Normal-vs-Stage4 |
2.15519999624547E-08 |
| Stage1-vs-Stage2 |
9.651800E-01 |
| Stage1-vs-Stage3 |
4.866000E-01 |
| Stage1-vs-Stage4 |
1.396190E-01 |
| Stage2-vs-Stage3 |
5.147000E-01 |
| Stage2-vs-Stage4 |
1.614780E-01 |
| Stage3-vs-Stage4 |
1.704390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.00932628710871E-13 |
| Normal-vs-AfricanAmerican |
3.20360404870712E-11 |
| Normal-vs-Asian |
1.544320E-03 |
| Caucasian-vs-AfricanAmerican |
8.897600E-01 |
| Caucasian-vs-Asian |
6.946600E-01 |
| AfricanAmerican-vs-Asian |
6.602000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.74336109384876E-13 |
| Normal-vs-Female |
3.81450004915962E-09 |
| Male-vs-Female |
2.631800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.73859999996751E-06 |
| Normal-vs-Extreme_Weight |
1.63091762317435E-12 |
| Normal-vs-Obese |
3.2072999811561E-09 |
| Normal-vs-Extreme_Obese |
1.8703999999925E-06 |
| Normal_Weight-vs-Extreme_Weight |
1.659810E-01 |
| Normal_Weight-vs-Obese |
9.446400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.017800E-01 |
| Extreme_Weight-vs-Obese |
4.964300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.765200E-01 |
| Obese-vs-Extreme_Obese |
7.960200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.275100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.15339959805283E-11 |
| Normal-vs-Age(61-80Yrs) |
1.6938672686706E-12 |
| Normal-vs-Age(81-100Yrs) |
1.04369999998077E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.121800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.991990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.525600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.968640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.473800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.111800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.41440000214865E-08 |
| Normal-VS-KIRP CIMP |
1.429860E-02 |
| Normal-VS-Unclassified PRCC |
4.93779999999333E-06 |
| Type1 PRCC-VS-Type2 PRCC |
2.674200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.693600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.387800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.934400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.312600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.864400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.51090284517386E-11 |
| Normal-vs-N1 |
2.44419999999579E-05 |
| Normal-vs-N2 |
1.07299999996258E-07 |
| N0-vs-N1 |
8.354800E-01 |
| N0-vs-N2 |
9.750200E-02 |
| N1-vs-N2 |
1.495380E-01 |
|
|
